Meeting
2015 ASCO Annual Meeting
Defining the immunologic phenotype of thymic epithelial tumors.
Authors
Jarushka Naidoo
Memorial Sloan Kettering Cancer Center, New York, NY
Jarushka Naidoo , Keith Steele , Camelia S. Sima , Jianda Yuan , Paul B. Robbins , Andre L. Moreira , Maria Catherine Pietanza , Jedd D. Wolchok , Gregory J. Riely , Naiyer A. Rizvi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Thymic Malignancies
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7516)
DOI
10.1200/jco.2015.33.15_suppl.7516
Abstract #
7516
Poster Bd #
263
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2018 ASCO Annual Meeting
Treg infiltration and the expression of immune checkpoints associated with T cell exhaustion in AML.
First Author: Patrick Williams
Poster
2017 ASCO Annual Meeting
Gene expression analysis of tumor biopsies from a trial of durvalumab to identify subsets of NSCLC with shared immune pathways.
First Author: Katie Streicher
Poster
2021 ASCO Annual Meeting
Examination of the tumor immune microenvironment (TIME) with multispectral immunofluorescence (m-IF): Association of markers with prognosis and bevacizumab (bev) benefit in NRG Oncology/NSABP C-08.
First Author: Katherine L. Pogue-Geile